The Global Influenza Vaccines Market Size is estimated to expand rapidly in coming years, at a CAGR of 5.97% from 2018 to 2025. In 2017, the global market valuation was USD 3.31 billion, and it is anticipated to be greater than USD xx.xx billion by 2025. Influenza virus, generally referred to as flu is a common infectious disease. Its symptoms include a cough, fever, muscle pain, joint pain, and severe headaches. Sometimes, influenza illness can even occasionally lead to death. As per World Health Organization (WHO), hospitalization related to severe illness affected with influenza ranged between 3.0 to 5.0 million and in which deaths related to influenza virus ranged in between 290,000 to 650,000 in the year 2017. There are various types of influenza vaccines such as adjuvant inactivated influenza vaccine, inactivated influenza vaccine, live attenuated influenza vaccine, toxoid vaccine, and recombinant influenza vaccine. The worldwide spread of influenza virus epidemic is expected to drive the influenza vaccines market size over the projected period.

Global Market Growth Opportunities (Revenue, Growth) By 2017-2025

This global market study report analysis offers in-depth insights, revenue details, and other vital information regarding the global influenza vaccines market, and the various trends, drivers, restraints, opportunities, and threats in the target market till 2025. The report offers insightful and detailed information regarding the various key players operating in the market, their financials, supply chain trends, technological innovations, key developments, apart from future strategies, acquisitions & mergers, and market footprint. The global influenza vaccines market report has been segmented on the basis of type, application, and region. It includes the estimation of the market size, in terms of value, with respect to 4 main geographies, namely, North America, Europe, APAC, and RoW.    

Market Dynamics

The rising number of influenza vaccines approvals is expected to augment the influenza vaccines market size on a global scale. Increasing number of government initiatives towards the development of various vaccines to treat multiple health disorders is further anticipated to push the influenza vaccines market towards growth. For example, the Bill and Malinda Gates Foundation in April 2018, announced a sum of US$ 12.0 million along with Lucy and Larry page for researchers to present innovative ideas, affordable and effective flu vaccines. Additionally, National Institute of Allergy and Infectious Disease (NIAID) in May 2018, supported the trial of universal influenza vaccines, which will, in turn, provide significant growth opportunities for the global influenza vaccines market size.

Continual mutation of the influenza virus has resulted in the advent of a newer virus, which is unaffected by the existing vaccines, which in turn leading to newer R&D practices to come up with newer vaccine formulae which creates a significant hike in the vaccines’ price. This is expected to be one of the major restraining factors of the global influenza vaccines market size.

Segment Analysis

Live attenuated influenza vaccines (LAIV) segment is expected to dominate the global influenza vaccines market over the forecast period, due to their immunity-boosting abilities by weakening the influenza viruses. Lesser side effects associated with LAIV and availability of a wide range of approved LAIV Such as Fluenz and FluMist is also contributing a significant share in driving the growth of this segment.

Among vaccine types, multivalent vaccines especially quadrivalent influenza vaccines are expected to dominate the market during the forecast period, due to their approval from FDA, low cost and their suitability to be consumed by population belonging above the age group of 2 years.

Regional Analysis

The global influenza vaccines market is divided into regions that are North America - U.S, Canada, Other; Asia-Pacific -India, Japan, China, Australia, Other; Europe - UK, Russia, France, Brazil, Other; Middle East and Africa. Every region analysis details in sense of growth, revenue, volume, challenges, and opportunities with the regional and global key players. North America is expected to hold a prime market share in the global influenza vaccines market owing to rising numbers of R&D activities by some of the major players of the market along with government support to come up with novel vaccine portfolio for the treatment of influenza virus.

Global Influenza Vaccines Market Size, Share Analysis By Region 2017

Asia Pacific influenza vaccines market is expected to witness a prime growth rate during the forecast period, owing to the increase in geriatric population, coupled with the economic growth in developing nations like China and India, which can lead to the expanding healthcare expenditure capacity in the region, which in turn will drive the Asia Pacific influenza vaccines market over the projected period.

Global Influenza Vaccines Market Study Objective

1. To forecast the market size of influenza vaccines market, along with describing and defining the market, in terms of volume and revenue as well as market opportunities for stakeholders, in order to provide a competitive landscape for global market players.

2. Market analysis and forecast of influenza vaccines market on the basis of region, substrate and application or end-use industry. To profile major market players, and to analyze their market shares and essential competencies comprehensively.

3. To analyze and elaborate significant factors that will have major impact on the growth of influenza vaccines market, such as drivers, restraints, challenges and opportunities.

4. Regional analysis of influenza vaccines market, to induce market size of five global major regions, which include, Europe, North America, South America, Middle East & Africa and Asia Pacific.

5. Strategic analysis of micromarkets, in terms of individual prospects, opportunities, growth trends and their involvement in overall market.

6. To provide detailed analysis of competitive and strategic developments in the influenza vaccines market like new product launch, partnership & agreement, investment & expansion, and company merger & acquisitions.

Key Players Landscape

Some of the key players operating in the influenza vaccines market include GlaxoSmithKline plc, Novartis International A.G., Sanofi S.A., Johnson & Johnson Inc., and CSL Limited among others. Major market players are focusing on acquisition activities to expand their product portfolio, along with concerns to improve their market share and geographical reach. For instance, In August 2017, Sanofi acquired Protein Sciences, a U.S.-based vaccines biotechnology company for the expansion of its influenza vaccine product portfolio. As a result of this acquisition, Flubok that was the only recombinant protein-based influenza vaccine approved by the U.S. Food and Drug Administration (FDA), which got added to Sanofi Pasteur’s influenza vaccine product portfolio.

Global Influenza Vaccines Market Study Report Offer You!

The global market study report gives an idea about market size, share, stock, equity, investment and total price analysis. Also, the report provides comprehensively industry insights with all major factors such as market credit, allocation, demand, distribution, market scope, key players, end user & applications, provisions, livestock, commodities and industry economics analysis, future growth & forecast. The global market report includes all depth data like pre-market emphasis, market survey, market investment, industry advice, portfolio, finance, access, trade, market exploration, industry review and market predication & projection to develop effective strategies for optimizing their market position.